Eagle Bay Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-1,138
| Closed | -$105K | – | 459 |
|
2024
Q4 | $105K | Sell |
1,138
-100
| -8% | -$9.24K | 0.07% | 200 |
|
2024
Q3 | $104K | Hold |
1,238
| – | – | 0.04% | 280 |
|
2024
Q2 | $84.9K | Sell |
1,238
-156
| -11% | -$10.7K | 0.05% | 257 |
|
2024
Q1 | $102K | Buy |
1,394
+28
| +2% | +$2.05K | 0.06% | 205 |
|
2023
Q4 | $111K | Sell |
1,366
-232
| -15% | -$18.8K | 0.07% | 196 |
|
2023
Q3 | $120K | Buy |
1,598
+219
| +16% | +$16.4K | 0.06% | 215 |
|
2023
Q2 | $106K | Sell |
1,379
-80
| -5% | -$6.17K | 0.06% | 208 |
|
2023
Q1 | $121K | Sell |
1,459
-187
| -11% | -$15.5K | 0.07% | 198 |
|
2022
Q4 | $141K | Buy |
1,646
+241
| +17% | +$20.7K | 0.08% | 175 |
|
2022
Q3 | $87K | Buy |
1,405
+313
| +29% | +$19.4K | 0.05% | 223 |
|
2022
Q2 | $67.5K | Buy |
1,092
+731
| +202% | +$45.2K | 0.04% | 289 |
|
2022
Q1 | $21K | Sell |
361
-827
| -70% | -$48.1K | 0.02% | 226 |
|
2021
Q4 | $86K | Sell |
1,188
-858
| -42% | -$62.1K | 0.05% | 212 |
|
2021
Q3 | $142K | Buy |
2,046
+1,209
| +144% | +$83.9K | 0.08% | 164 |
|
2021
Q2 | $59K | Buy |
+837
| New | +$59K | 0.05% | 282 |
|